I agree, but this part "MSB gets a tap on the shoulder from FDA based on interim results - (leaked as POSITIVE)" is sheer speculation.
Have you found anything at all to back this up? Demonstrably lower mortality rates anywhere? Anecdotal evidence of increased survival rates? Given the spread of the treatment facilities across the US, and the large number of infections and hospitalisations it's not possible to draw any meaningful inferences from the data available.
Ann: MSB Completes Financing For Covid-19 ARDS Manufacturing, page-97
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |